Insmed Officer Files Intent to Sell $1.8M in Stock (INSM)
INSMED Inc
Subscribe to track INSM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insmed Officer Files Intent to Sell $1.8M in Stock (INSM)
Company: INSMED Inc (INSM) Form: 144 | Filed: 2025/12/18 Significance: Low
Insider: William Lewis Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 10,699 • Approx. Value: $1,786,437
Key Insight: The proposed sale, valued at ~$1.8M, represents a negligible fraction (0.004%) of Insmed's $41.21B market cap. The transaction was filed under a pre-scheduled 10b5-1 trading plan, reducing its significance as an indicator of insider sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: INSMED Inc (INSM)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Insmed has filed a notice of proposed sale for approximately $1.8 million worth of common stock, executed under a pre-arranged 10b5-1 trading plan.
- Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to have a noticeable impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | INSMED Inc |
| Ticker Symbol | INSM |
| CIK | 0001104506 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | William Lewis |
| CIK | 0001402051 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025/12/18 (Approximate) |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 10,699 |
| Price Per Share | $166.97 (Approximate) |
| Total Value | $1,786,437 |
| Shares Owned After | Not Available |
| Ownership Type | Not Available |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,786,437 |
| % of Market Cap | 0.0043% |
| Shares Transacted | 10,699 |
| % of Shares Outstanding | 0.0051% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap company with a market capitalization of $41.21 billion, a transaction of $1.8 million is considered routine and financially insignificant.
- Transaction Significance: The sale represents a negligible percentage of both the market cap (<<0.1%) and shares outstanding (<<0.1%), falling well below the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is de minimis compared to the company's overall valuation. The pre-scheduled nature of the sale via a 10b5-1 plan indicates it is likely for personal financial planning rather than a reaction to non-public information.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is very small compared to the stock's typical daily trading volume.
- Sentiment Indicator: Neutral. This type of routine, pre-planned insider sale does not typically influence market sentiment.
Additional Context
Special Circumstances
- The filing indicates the sale is pursuant to a trading plan adopted on September 4, 2025. This is a Rule 10b5-1 plan, which allows insiders to set up a pre-arranged schedule for selling stocks, providing an affirmative defense against insider trading allegations.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.